Found 17 matching trials
A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL
N/AThis is a prospective, observational, multicenter, cohort study with 400 ne...
Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai
Phase III Study of Tucidinostat in Combination With R-CHOP in Patients With Newly Diagnosed Double-Expressor DLBCL
PHASE3Tucidinostat (formerly known as chidamide) is an oral subtype-selective his...
Location
Peking University Cancer Hospital
Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
PHASE2This is a prospective, open-label, single arm, multicenter clinical study t...
Location
Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University
Study Evaluating the Safety and Efficacy of C-CHOP in Untreated Subjects With Angioimmunoblastic T Cell Lymphoma
PHASE2This is a single-arm, open-label phase 2study of Chidamide in combination w...
AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH
PHASE3This study is an open label, multicenter study. Subjects are randomized at ...
Status
Enrolling By Invitation
Location
Tianjin Medical University Cancer Insititute & Hospital
Linperlisib Combined With Chidamide in Patients With PTCL
PHASE1The phase Ib part of this study aims to determine the recommended phase II ...
Location
Affiliated Cancer Hospital of Zhengzhou University
Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL
PHASE2Zanubrutinib, as a new generation of BTK inhibitors, has shown more potent ...
Location
Sun Yat-sen University Cancer Center
New Genotype-guided Treatment in Newly Diagnosed PTCL
PHASE1This is a phase I/II study evaluate the safety and efficacy targeted agents...
Chidamide Plus R-CHOP in Elderly DLBCL
PHASE2This is a prospective, single-arm, open-label phase II study of Chidamide i...
Location
Shanghai Ruijin Hospital
Dynamic CtDNA-guided Targeted Therapy in DLBCL
PHASE2This is a prospective, single-arm, noninferiority trial involving patients ...
Location
Multiple Locations